Long-Term Averaged Spectrum Descriptors of Dysarthria in Patients With Parkinson's Disease Treated With Subthalamic Nucleus Deep Brain Stimulation.

Svihlik, Jan; Novotny, Michal; Tykalova, Tereza; Polakova, Kamila; Brozova, Hana; Kryze, Petr; Sousa, Mario; Krack, Paul; Tripoliti, Elina; Ruzicka, Evzen; Jech, Robert; Rusz, Jan (2022). Long-Term Averaged Spectrum Descriptors of Dysarthria in Patients With Parkinson's Disease Treated With Subthalamic Nucleus Deep Brain Stimulation. Journal of speech, language, and hearing research : JSLHR, 65(12), pp. 4690-4699. American Speech-Language-Hearing Association 10.1044/2022_JSLHR-22-00308

Text Svihlik__2022__Long-Term_Averaged_Spectrum_Descriptors__of_Dysarthria_in_Patients.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (348kB)

PURPOSE

This study aimed to evaluate whether long-term averaged spectrum (LTAS) descriptors for reading and monologue are suitable to detect worsening of dysarthria in patients with Parkinson's disease (PD) treated with subthalamic nucleus deep brain stimulation (STN-DBS) with potential effect of ON and OFF stimulation conditions and types of connected speech.

METHOD

Four spectral moments based on LTAS were computed for monologue and reading passage collected from 23 individuals with PD treated with bilateral STN-DBS and 23 age- and gender-matched healthy controls. Speech performance of patients with PD was compared in ON and OFF STN-DBS conditions.

RESULTS

All LTAS spectral moments including mean, standard deviation, skewness, and kurtosis across both monologue and reading passage were able to significantly distinguish between patients with PD in both stimulation conditions and control speakers. The spectral mean was the only LTAS measure sensitive to capture better speech performance in STN-DBS ON, as compared to the STN-DBS OFF stimulation condition (p < .05). Standardized reading passage was more sensitive compared to monologue in detecting dysarthria severity via LTAS descriptors with an area under the curve of up to 0.92 obtained between PD and control groups.

CONCLUSIONS

Our findings confirmed that LTAS is a suitable approach to objectively describe changes in speech impairment severity due to STN-DBS therapy in patients with PD. We envisage these results as an important step toward a continuum development of technological solutions for the automated assessment of stimulation-induced dysarthria.

SUPPLEMENTAL MATERIAL

https://doi.org/10.23641/asha.21644798.

Interest & Impact

Downloads

2 since deposited on 23 Dec 2022
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item